✦ LIBER ✦

Beyond trastuzumab: New treatment options for HER2-positive breast cancer

✍ Scribed by Kamal S. Saini; Hatem A. Azim Jr; Otto Metzger-Filho; Sherene Loi; Christos Sotiriou; Evandro de Azambuja; Martine Piccart

Book ID: 114316686
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 255 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(11)70289-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Adjuvant Trastuzumab Therapy for HER2-Po

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Mohammad Jahanzeb 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

Duration of trastuzumab for HER2-positiv

Duration of trastuzumab for HER2-positive breast cancer

✍ Montemurro, Filippo; Aglietta, Massimo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 203 KB

Neoadjuvant trastuzumab + FEC for HER2-p

Neoadjuvant trastuzumab + FEC for HER2-positive breast cancer

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Trastuzumab Emtansine for HER2-Positive

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

✍ Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselg 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 365 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB